Efe Eworuke

Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration

Presentation(s):

• SP12H - No Differential Risk of Cutaneous Small Vessel Vasculitis with Oral Anticoagulant Use Among Patients with Atrial Fibrillation

  Tuesday, August 24, 2021
  5:15 PM – 6:30 PM US Eastern Time

• OP-17A - Characteristics and Outcomes of Pregnancies in Women with Heart Failure: A Retrospective Cohort Study in the Sentinel System

  Wednesday, August 25, 2021
  4:30 PM – 6:00 PM US Eastern Time